Bacillus subtilis and application thereof in adenosine production through fermentation
Bacillus subtilis HDCC12-21027 obtained through microwave mutagenesis screening solves the problems of unstable genetic traits and unstable yields of adenosine fermented strains, and achieves high purity and high yields of adenosine production, simplifies the process and reduces costs .
Patent Information
- Application Number
- CN202411048915.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-31
- Publication Date
- 2024-11-22
AI Technical Summary
The existing adenosine fermented strains have problems such as unstable genetic traits, unstable yields, low glucose tolerance, high cost and low purity, making it difficult to achieve industrial production.
Bacillus subtilis HDCC12-21027 obtained through microwave mutagenesis screening. This strain has stable hereditary traits, non-nutritional defects, high glucose tolerance, and strong nitrogen source adaptability. It is suitable for industrial adenosine production.
The high purity (≥91%) and high yield of adenosine are achieved, the fermentation and purification process is simplified, the industrial production costs are reduced, and the stability of product quality is improved.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and specifically relates to a strain of Bacillus subtilis and application thereof in fermentation production of adenosine. Background Art
[0002] Adenosine, chemical name 6-amino-9-β-D-ribofuranosyl-9-hydrogen purine, is an important nucleotide derivative and is the product of adenine nucleotide dephosphorylation. As an endogenous nucleoside distributed throughout human cells, it can directly enter the myocardium and generate adenylic acid through phosphorylation, participate in myocardial energy metabolism, and also participate in dilating coronary vessels and increasing blood flow. It can be used to treat supraventricular tachycardia, supraventricular arrhythmias related to the atrioventricular chamber, and treat angina pectoris, myocardial infarction, coronary insufficiency, arteriosclerosis, essential hypertension, cerebrovascular disorders, sequelae of stroke, progressive muscular atrophy, etc. Adenosine has physiological effects on the cardiovascular system and many other systems and tissues of the body. Adenosine plays an important role in biochemistry, including transferring energy in the form of adenosine triphosphate (ATP) or adenosine diphosphate (ADP), or transmitting signals in the form of cyclic adenosine monophosphate (cAMP). In addition, adenosine is an inhibitory neurotransmitter and plays an important role in neurotransmission.
[0003] At present, the existing technology for producing adenosine is RNA hydrolysis, chemical method and fermentation method. The chemical synthesis method for synthesizing adenosine has a series of problems such as high cost, cumbersome reaction and low yield. RNA hydrolysis method will obtain 4 kinds of nucleoside substances at the same time, which brings difficulties to the subsequent separation. In comparison, the microbial fermentation method has a lower cost for producing adenosine, the raw materials are easy to obtain, and the efficiency of producing adenosine is higher, so it has an absolute advantage in the production of adenosine.
[0004] However, there are also many problems in the adenosine fermentation process. One is that adenosine mostly uses genetically engineered strains or strains after physical and chemical mutagenesis as production strains, such as CN102154165B discloses a guanine auxotrophic type and xanthosyl aminotransferase deficiency obtained by low-energy ion beam mutagenesis of Bacillus subtilis; CN1724646A discloses a HJ04130 isoleucine and valine-deficient adenosine production strain obtained by DES mutagenesis; but the inventors found that auxotrophic strains generally have problems such as genetic traits and unstable yields, serious strain degradation, high reversion mutation rate, poor product quality stability, and are not conducive to industrial production. And the glucose tolerance of bacteria disclosed in the prior art is not high, and glucose tolerance is an important indicator of the industrial application prospects of strains. Strains with good glucose tolerance can not only tolerate high concentrations of substrates, but also tolerate high concentrations of osmotic pressure, which is of great significance for increasing the concentration of products. Secondly, the development of adenosine as an injection requires very high quality requirements for raw materials. The original strains usually have the problem of low purity of adenosine fermentation, which leads to the complication of downstream processes and high purification costs. Thirdly, adenosine fermentation requires very rich nutrition (organic nitrogen source), which makes the cost of adenosine fermentation very high. Fourthly, the existing high-level adenosine-producing bacteria have not reached the large-scale production stage, and industrial scale-up is a very big difficulty for genetically engineered bacteria. Therefore, it is very necessary to develop a non-nutritional bacteria that stably produces adenosine and can be stably scaled up for industrialization. Summary of the invention
[0005] In view of the problems existing in the prior art, the present invention obtains an adenosine production strain suitable for industrial production through screening and mutagenesis, which has stable genetic traits (not easy to degenerate), is non-nutritional deficiency type, has high fermentation adenosine purity, has high glucose tolerance, and has strong nitrogen source adaptability (wide selectivity).
[0006] One of the objects of the present invention is to provide a new Bacillus subtilis HDCC12-21027, which is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: Beijing, China, with a deposit number of CGMCC NO.23448 and a deposit date of September 18, 2021.
[0007] The Bacillus subtilis HDCC12-21027 of the present invention is obtained by microwave mutagenesis screening using Bacillus subtilis HDCC112-20636 as a starting strain.
[0008] The second object of the present invention is to provide a new use of Bacillus subtilis HDCC12-21027 or its seed solution or fermentation solution or bacterial suspension or culture solution in the preparation of adenosine or a pharmaceutical composition containing adenosine.
[0009] The third object of the present invention is to provide a method for preparing adenosine, comprising fermenting and preparing adenosine using the above-mentioned Bacillus subtilis HDCC12-21027.
[0010] Furthermore, the fermentation process includes aerobic fermentation in a fermentation medium containing assimilable carbon source and / or nitrogen source.
[0011] In a preferred embodiment, the carbon source is selected from glucose, glycerol, sucrose, dextrin, starch, maltose, lactose, sorbitol, mannitol, xylose or any mixture thereof; preferably glucose and sucrose.
[0012] In a preferred embodiment, the nitrogen source is selected from ammonium salt, nitrate, urea, yeast extract, beef extract, corn steep liquor, peptone, fish meal or any mixture thereof; preferably ammonium salt, nitrate, urea, yeast extract, corn steep liquor or any mixture thereof, further preferably ammonium sulfate, urea, yeast extract, corn steep liquor.
[0013] In a preferred embodiment, the fermentation medium further comprises an inorganic salt, and the inorganic salt is selected from sulfates, phosphates, hydrochlorides, magnesium salts, manganese salts, potassium salts, sodium salts, and calcium salts, preferably one of dipotassium hydrogen phosphate or potassium dihydrogen phosphate, magnesium sulfate, manganese sulfate or manganese chloride, potassium chloride, sodium chloride, and calcium carbonate, or a mixture of any of them.
[0014] In a preferred embodiment, the fermentation medium contains 10-24% glucose, 0.5-1.0% yeast extract, 0.5-1.0% corn steep liquor, 0.2-2.0% ammonium chloride, 0.05-0.3% KH2PO4, 0.001-0.01% MnSO4, 0.1-0.8% urea, 0.01-2.0% MgSO4, and 0.1-3.0% CaCO3.
[0015] In a preferred embodiment, the fermentation temperature is 30-37° C., the culture medium pH is 6.0-8.0, and the culture time is 48-96 hours.
[0016] In a preferred embodiment, the Bacillus subtilis is inoculated into the fermentation medium by seed liquid to carry out the fermentation culture;
[0017] Wherein, the seed solution is obtained by culturing Bacillus subtilis HDCC12-21027 in a seed culture medium;
[0018] The seed culture conditions are as follows: the seed culture temperature is 30-37°C; the medium pH is 6.0-8.0; the culture time is 8-20 hours;
[0019] The seed culture medium contains 5-40 g / L of glucose, 2-20 g / L of peptone, 3-25 g / L of yeast extract, 10-50 g / L of yeast extract powder, 0.2-1 g / L of calcium chloride, 0.2-2 g / L of magnesium sulfate and 0.2-5 g / L of potassium dihydrogen phosphate.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] The present invention provides a strain of adenosine-producing Bacillus subtilis, which is a non-genetically engineered strain obtained from a naturally isolated strain through microwave mutation, and has more stable genetic traits and is not prone to degeneration. The strain also has the characteristics of high HPLC purity (≥91%) of fermented adenosine synthesis, high glucose tolerance concentration (24%), not easy to be contaminated, and wide nitrogen source selectivity, which is conducive to simplifying the fermentation and purification process, stabilizing the quality of industrialized adenosine products, and reducing the cost of industrialized adenosine production. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 HPLC spectrum of the fermentation broth of the starting strain;
[0023] Figure 2 HPLC profile of the fermentation broth of strain HDCC12-21027;
[0024] Figure 3 This is the HPLC profile of the shake flask fermentation broth of strain 5-36. DETAILED DESCRIPTION
[0025] The present invention is described below by specific embodiments. Unless otherwise specified, the technical means used in the present invention are methods known to those skilled in the art. In addition, the embodiments should be understood as illustrative rather than limiting the scope of the present invention, and the essence and scope of the present invention are limited only by the claims. For those skilled in the art, various changes or modifications to the material composition and dosage in these embodiments, without departing from the essence and scope of the present invention, also belong to the protection scope of the present invention.
[0026] Example 1
[0027] Wastewater samples were taken from the temporary storage pool of the West Lake MSG factory in Yuhang District, Hangzhou City, Zhejiang Province, and numbered and recorded. 1 ml of each sample was inoculated into LB liquid culture medium, enriched and cultured at 35°C for 4 hours, then placed in an 80°C water bath for 40 minutes, cooled to room temperature, and gradient diluted. 0.1 mL of 10-1 to 10-6 gradient dilutions were inoculated and coated on LB agar culture medium, and inverted and cultured at 35°C overnight. White, rough-surfaced, and irregularly shaped colonies were selected and inoculated into a 250 ml Erlenmeyer flask containing 20 ml LB liquid culture medium (LB culture medium (peptone 10 g / L, yeast extract powder 10 g / L, sodium chloride 5 g / L) pH was adjusted to 7.0 before disinfection, and the disinfection conditions were 121-123°C, 30 minutes), and placed on a shaker at 35°C and 250 rpm for 30 hours. After the cultivation is completed, the supernatant of the fermentation broth is centrifuged and chromatographic detection is performed using n-butanol: glacial acetic acid: pure water = 4:1:1 as the developing solvent. 5 μL of the sample supernatant with the same Rf value as the adenosine reference is selected and mixed in 5 ml of 0.1 mol / L hydrochloric acid solution. The absorbance value is measured at 260 nm. Adenosine content (g / L) = absorbance value × 18.87.
[0028] The strain corresponding to the sample with the highest absorbance value was selected, and continuous streaking separation and purification were performed. The purified strain with the highest yield was selected using the same screening method as above, and was preserved and numbered HDCC112-20636.
[0029] Example 2
[0030] Bacterial strain resuscitation and activation: Take the working bacterial strain glycerol tube (HDCC112-20636), thaw it at room temperature, draw 0.1 ml of bacterial suspension and inoculate it onto the LB solid plate, spread it evenly, and culture it in a 35°C incubator for 24 hours to obtain a single colony that has been activated and resuscitated.
[0031] Preparation of liquid seeds: Take a single colony that has been activated and revived, pick up a single colony with an inoculation spatula, inoculate it into a 500ml Erlenmeyer flask containing 100ml LB liquid culture medium, wrap it up and place it on a shaker at 35℃ and 250rpm for 20h, and control the OD value of the seed liquid to be ≥0.5.
[0032] Before disinfection of LB liquid culture medium, adjust the pH to 7.0, and the disinfection conditions are 121-123°C and 30 min.
[0033] Fermentation culture: Take the qualified liquid seeds and inoculate them into a 250ml Erlenmeyer flask containing 40ml liquid fermentation medium at a ratio of 10% (V / W). Wrap it and place it on a shaker at 35°C and 250rpm for 3 days.
[0034] The liquid fermentation medium formula is composed of: glucose 10.0%, yeast extract 1.0%, corn steep liquor 0.5%, NH4Cl2.0%, KH2PO40.2%, MnSO40.005%, urea 0.375%, MgSO42.0%, CaCO33.0%, pH 7.5, and the disinfection conditions are 121-123°C, 30min. Sample processing and detection: After the fermentation is completed, take 2ml of the fermentation liquid, centrifuge at 10000rpm for 10min to remove the bacteria, and then take the supernatant and filter it through a 0.45μm microporous filter membrane, and refer to the "Chinese Pharmacopoeia" 2020 Edition Part II for liquid chromatography analysis and determination. For details, see the attached Figure 1 In the fermentation broth obtained in this embodiment, the HPLC purity of adenosine is 0.56%, the HPLC purity of the impurity inosine is 4.05%, the HPLC purity of the impurity adenine is 0.57%, and the adenosine content is 0.12 g / L.
[0035] Example 3
[0036] The original strain (HDCC112-20636) was used as the starting strain, and its fresh bacterial moss was collected, washed with sterile physiological saline, and shaken with glass beads to obtain a bacterial suspension, which was placed in a microwave oven with a power setting of 700W and a mutagenesis time of 9 seconds. After different gradient dilutions of the suspension after mutagenesis, 0.1ml was aspirated and applied to the LB agar plate, inverted and cultured at 35°C overnight, and different colonies were randomly selected and inoculated into a 250ml triangular flask with 20ml LB liquid culture medium (LB culture medium was adjusted to pH 7.0 before disinfection, and the disinfection conditions were 121-123°C, 30min), and placed on a shaker at 35°C and 250rpm for 30h of shaking culture. After the culture was completed, 5μL of the fermentation broth centrifuged supernatant was mixed in 5ml0.1mol / L hydrochloric acid solution, and the absorbance value was measured at 260nm. The adenosine content (g / L) = absorbance value × 18.87. The strains corresponding to the samples with the top 10% absorbance values were selected and rescreened and verified as follows.
[0037] Resuscitation and activation of bacterial strains: Take the glycerol tube of the primary screened bacterial strain, thaw it at room temperature, aspirate 0.1 ml of the bacterial suspension and inoculate it onto the LB solid plate, spread it evenly, and culture it in a 35°C incubator for 24 hours to obtain a single colony that has been activated and revived.
[0038] Preparation of liquid seeds: Take a single colony that has been activated and revived, pick up a single colony with an inoculation spatula, inoculate it into a 500ml Erlenmeyer flask containing 100ml LB liquid culture medium, wrap it up and place it on a shaker at 35℃ and 250rpm for 20h, and control the OD value of the seed liquid to be ≥0.5.
[0039] Before disinfection of LB liquid culture medium, adjust the pH to 7.0, and the disinfection conditions are 121-123°C and 30 min.
[0040] Fermentation culture: Take the qualified liquid seeds and inoculate them into a 250ml Erlenmeyer flask containing 40ml liquid fermentation medium at a ratio of 10% (V / W). Wrap it and place it on a shaker at 35°C and 250rpm for 3 days.
[0041] The liquid fermentation medium formula is composed of: glucose 10.0%, yeast extract 1.0%, corn steep liquor 0.5%, NH4Cl2.0%, KH2PO40.2%, MnSO40.005%, urea 0.375%, MgSO42.0%, CaCO33.0%, pH 7.5, disinfection conditions are 121-123℃, 30min. pH 7.5, disinfection conditions are 121-123℃, 30min.
[0042] Sample processing and detection: After the fermentation is completed, 2 ml of the fermentation broth was taken and centrifuged at 10000 rpm for 10 min to remove the bacteria, and then the supernatant was filtered through a 0.45 μm microporous filter membrane, and liquid chromatography analysis was performed according to Part II of the 2020 edition of the Chinese Pharmacopoeia. A high-yield strain was screened and obtained. In the fermentation broth, the HPLC purity of adenosine was 92.7%, the HPLC purity of the impurity inosine was 0.37%, and the HPLC purity of the impurity adenine was 0.08%. The adenosine yield was 3.51 g / L, see attached Figure 2 The original preservation number of this strain is HDCC12-21027. It was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration on September 18, 2021, with the preservation number CGMCC NO.23448.
[0043] Example 4
[0044] The strain (HDCC12-21027) was inoculated on the LB agar plate and incubated at 35℃ for 24h. The colony was dirty white, with a rough surface, opaque, no flash, and spread irregularly. The physiological and biochemical identification characteristics were liquefied gelatin, hydrolyzed starch, positive VP test, reduced nitrate, and negative lecithinase test. The carbon source utilization was best with glucose, glycerol, sucrose, dextrin, and starch, followed by maltose and lactose, and sorbitol, mannitol, and xylose were relatively poor. The nitrogen source utilization was relatively comprehensive, and both organic nitrogen sources and conventional inorganic nitrogen sources such as ammonium salts and urea were all acceptable. The results of the pH test showed that the optimal growth pH range was 5.2-8.6, and the results of the temperature test showed that the optimal growth temperature was 35℃, and the more suitable range was 25-42℃.
[0045] The experiment was conducted according to the relevant contents in the Molecular Cloning Experiment Guide. Mycelium was collected, and then total DNA was extracted using the Ezup column bacterial genomic DNA extraction kit. The universal primers 27F (AGTTTGATCMTGGCTCAG) / 1492R (GGTTACCTTGTTACGACTT) were used for 16S rDNA sequence amplification, and PCR product detection was performed using 0.8% agarose gel electrophoresis (150V, 100mA20min). The PCR product was purified and recovered using the Shanghai Sangon SanPrep column PCR purification product kit (product number: SK8131, see the operation manual for details), and the purified PCR product was directly sent to Sangon Biotechnology (Shanghai) Co., Ltd. for sequence determination.
[0046] After proofreading, the 16S rDNA sequence (SEQ ID NO: 1) obtained by the strain (HDCC12-21027) was submitted to NCBI for BLAST comparison with the relevant sequences in GenBank. The results are shown in Table 1 (only the model strains with higher homology are listed in the table). After proofreading, the measured 16S rDNA sequence was compared with the sequences of related species and genera in the GenBank database for homologous sequence BLAST comparison. Combined with the results of physiological and biochemical tests, the strain was finally determined to be Bacillus subtilis.
[0047] Table 1 Homology of strain (HDCC12-21027) and typical model strains
[0048]
[0049]
[0050] Example 5
[0051] Take the adenosine production strain (HDCC12-21027) working strain library (F0 generation) glycerol tube, 0.1ml inoculated into a 500ml triangular flask containing 100ml LB liquid medium, wrapped and placed on a shaker at 35°C and 250rpm for shaking culture for 20h. The cultured seed solution was added with a protective agent to preserve the seeds at -80°C (F1 generation), and at the same time, it was inoculated into a glass fermenter at a ratio of 10% (V / W) for evaluation. In this way, the same method was continuously passed down to the 14th generation, and the fermentation culture was completed. After each generation of fermentation, 2ml of the fermentation liquid was taken, and the bacteria were removed by high-speed centrifugation at 10000rpm for 10min, and then the supernatant was filtered through a 0.45μm microporous membrane, and the liquid chromatography analysis was performed according to the second part of the 2020 edition of the Chinese Pharmacopoeia, and the adenosine yield, adenosine HPLC purity, HPLC purity of impurity inosine, and HPLC purity of impurity adenine were recorded, and the summary is shown in Table 2. The results showed that the production capacity of the adenosine-producing strain (HDCC12-21027) did not deteriorate after repeated freezing and continuous subculture for 14 generations, and the genetic traits were stable, as shown in Table 2.
[0052] The formula of liquid fermentation medium is: glucose 24%, yeast extract 1.0%, corn steep liquor 0.5%, NH4Cl2.0%, KH2PO40.2%, MnSO40.005%, urea 0.375%, MgSO42.0%, CaCO33.0%, pH 7.5, and the disinfection conditions are 121-123℃, 30min.
[0053] Table 2 Genetic stability data
[0054]
[0055] Example 6
[0056] Bacterial strain resuscitation and activation: Take the working bacterial strain glycerol tube (CGMCC NO.23448), thaw it at room temperature, draw 0.1 ml of bacterial suspension and inoculate it onto the LB solid plate, spread it evenly, and culture it in a 35°C incubator for 24 hours to obtain a single colony of activated and revived bacteria.
[0057] Preparation of liquid seeds: Take a single colony that has been activated and revived, pick up a single colony with an inoculation spatula, inoculate it into a 500ml Erlenmeyer flask containing 100ml LB liquid culture medium, wrap it up and place it on a shaker at 35℃ and 250rpm for 20h, and control the OD value of the seed liquid to be ≥0.5.
[0058] Before disinfection of LB liquid culture medium, adjust the pH to 7.0, and the disinfection conditions are 121-123°C and 30 min.
[0059] Fermentation culture: Take the qualified liquid seeds and inoculate them into 250ml Erlenmeyer flasks containing 40ml liquid fermentation medium with different glucose concentrations at a ratio of 10% (V / W). Wrap them and place them on a shaker at 35℃ and 250rpm for 3 days.
[0060] The liquid fermentation medium formula consists of: glucose (4-24%), yeast extract 1.0%, corn steep liquor 0.5%, NH4Cl 2.0%, KH2PO4 0.2%, MnSO4 0.005%, urea 0.375%, MgSO4 2.0%, CaCO3 3.0%, pH 7.5, and the disinfection conditions are 121-123°C, 30 minutes.
[0061] Sample processing and testing: After the fermentation is completed, 2 ml of the fermentation broth is taken, and the bacteria are removed by high-speed centrifugation at 10000 rpm for 10 minutes. Then the supernatant is filtered through a 0.45 μm microporous filter membrane, and the liquid chromatography analysis is performed according to the second part of the 2020 edition of the Chinese Pharmacopoeia. The adenosine production, HPLC purity of adenosine, HPLC purity of impurity inosine, and HPLC purity of impurity adenine in the fermentation broth of the test groups with different glucose concentrations are summarized in Table 3. The results show that when the glucose concentration is lower than 18%, the adenosine production increases with the increase of glucose concentration, but the HPLC purity of adenosine does not decrease. When the glucose concentration is higher than 18%, the adenosine production no longer increases, but even if the basic glucose concentration is increased to 24%, the growth of the strain, adenosine synthesis, and HPLC purity of adenosine do not show adverse effects.
[0062] Table 3 Effect of glucose concentration on fermentation process
[0063]
[0064]
[0065] Example 7
[0066] According to the formula of liquid fermentation medium, weigh all components except glucose, dissolve with drinking water, make up to volume, adjust pH and mix well, then dispense into sterile 250ml conical flasks in the clean workbench, and then add different volumes of sterilized concentrated glucose solution to make the final concentration of glucose in the liquid 0%, 4%, 12%, 18%, and 24%, respectively. Wrap it well, place it on a shaker at 37°C for 4 hours of shaking culture to obtain the test sample. For each sample to be tested, refer to the method for determining the total number of microorganisms in the 2020 edition of the "Chinese Pharmacopoeia" for the determination of the total number of colonies. The statistical results of the total number of colonies of each test sample are shown in Table 4:
[0067] Table 4 Total colony count
[0068]
[0069] From the results in Table 3, it can be seen that when 24% glucose was added to the culture medium, the growth of foreign bacteria in the adenosine fermentation medium was significantly reduced by an order of magnitude, indicating that the high concentration of 24% glucose has a significant inhibitory effect on the growth of foreign bacteria in the culture medium and can reduce the risk of contamination in adenosine fermentation.
[0070] Example 8
[0071] Bacterial strain resuscitation and activation: Take the working bacterial strain glycerol tube (CGMCC NO.23448), thaw it at room temperature, draw 0.1 ml of bacterial suspension and inoculate it onto the LB solid plate, spread it evenly, and culture it in a 35°C incubator for 24 hours to obtain a single colony of activated and revived bacteria.
[0072] Preparation of liquid seeds: Take a single colony that has been activated and revived, pick up a single colony with an inoculation spatula, inoculate it into a 500ml Erlenmeyer flask containing 100ml LB liquid culture medium, wrap it up and place it on a shaker at 35℃ and 250rpm for 20h, and control the OD value of the seed liquid to be ≥0.5.
[0073] Before disinfection of LB liquid culture medium, adjust the pH to 7.0, and the disinfection conditions are 121-123°C and 30 min.
[0074] Fermentation culture: Take the qualified liquid seeds and inoculate them into 250ml Erlenmeyer flasks containing 40ml liquid fermentation medium with different nitrogen sources at a ratio of 10% (V / W). Wrap it and place it on a shaker at 35°C and 250rpm for shaking culture for 3 days.
[0075] The formula of the liquid fermentation medium is as follows: different nitrogen sources, common components are glucose 24%, KH2PO4 0.2%, MnSO4 0.005%, MgSO4 2.0%, CaCO3 3.0%, pH 7.5, and the disinfection conditions are 121-123°C, 30min.
[0076] Sample processing and detection: After the fermentation, 2 ml of the fermentation broth was taken, and the bacteria were removed by high-speed centrifugation at 10000 rpm for 10 min. Then the supernatant was filtered through a 0.45 μm microporous filter membrane, and the liquid chromatography analysis was performed according to the second part of the 2020 edition of the Chinese Pharmacopoeia. The adenosine yield, HPLC purity of adenosine, HPLC purity of impurity inosine, and HPLC purity of impurity adenine in the fermentation broth of different nitrogen source screening tests were summarized in Table 5. The results showed that the strain had a very wide selectivity for nitrogen source utilization. It could utilize nutrient-rich fine nitrogen sources such as peptone, yeast extract, and corn steep liquor, and could also adapt to low-nutrient rough nitrogen sources such as soybean cake powder, soybean meal, corn protein powder, and silkworm pupa powder, and there was no significant difference in adenosine yield and HPLC purity.
[0077] Table 5 Effect of organic nitrogen source on fermentation process
[0078]
[0079] Comparative Example: Shake flask fermentation test of 5-36 strains
[0080] Bacterial strain resuscitation and activation: Take 5-36 bacterial strains (the strains are derived from the strains disclosed in the journal article "Selection of high-yield adenosine fermentation strains and process optimization") in a glycerol tube, thaw it at room temperature, draw 0.1 ml of bacterial suspension and inoculate it onto an LB solid plate, spread it evenly, and place it in a 35°C incubator for 24 hours to obtain activated and revived single colonies.
[0081] Preparation of liquid seeds: Take a single colony that has been activated and revived, pick up a single colony with an inoculation spatula, inoculate it into a 500ml Erlenmeyer flask containing 100ml LB liquid culture medium, wrap it up and place it on a shaker at 35℃ and 250rpm for 20h, and control the OD value of the seed liquid to be ≥0.5.
[0082] Before disinfection of LB liquid culture medium, adjust the pH to 7.0, and the disinfection conditions are 121-123°C and 30 min.
[0083] Fermentation culture: Take the qualified liquid seeds and inoculate them into 250ml Erlenmeyer flasks containing 40ml liquid fermentation medium with different glucose concentrations at a ratio of 10% (V / W). Wrap them and place them on a shaker at 35℃ and 250rpm for 3 days.
[0084] The liquid fermentation medium formula consists of: glucose (4-24%), yeast extract 1.0%, corn steep liquor 0.5%, NH4Cl 2.0%, KH2PO4 0.2%, MnSO4 0.005%, urea 0.375%, MgSO4 2.0%, CaCO3 3.0%, pH 7.5, and the disinfection conditions are 121-123°C, 30 minutes.
[0085] Sample processing and testing: After the fermentation is completed, take 2 ml of the fermentation liquid, centrifuge at 10000 rpm for 10 min to remove the bacteria, then take the supernatant and filter it through a 0.45 μm microporous filter membrane, and perform liquid chromatography analysis and determination according to Part II of the 2020 edition of the Chinese Pharmacopoeia. The HPLC spectrum is as attached. Figure 3 shown.
[0086] Experimental results: After testing, the HPLC purity of adenosine components in the shake flask fermentation liquid of strain 5-36 was 68.6%, the HPLC purity of inosine was 0.86%, and the HPLC purity of adenine was 0.15%.
Claims
1. A Bacillus subtilis HDCC12-21027, deposited in the General Microbiology Center of China Microorganism Culture Collection Administration (CGMCC), with a deposit number of CGMCC NO.23448 and a deposit date of September 18, 2021.
2. A fermentation broth containing the Bacillus subtilis HDCC12-21027 according to claim 1.
3. Use of the Bacillus subtilis HDCC12-21027 or its seed solution or fermentation solution or bacterial suspension or culture solution as claimed in claim 1 in the preparation of adenosine or a pharmaceutical composition containing adenosine.
4. A method for preparing adenosine, characterized in that: The method comprises fermenting and preparing the product using the Bacillus subtilis HDCC12-21027 as claimed in claim 1.
5. The preparation method according to claim 4, characterized in that: The fermentation process comprises aerobic fermentation in a fermentation medium containing assimilable carbon source and / or nitrogen source.
6. The preparation method according to claim 5, characterized in that: The carbon source is selected from glucose, glycerol, sucrose, dextrin, starch, maltose, lactose, sorbitol, mannitol, xylose or any mixture thereof; preferably glucose and sucrose.
7. The preparation method according to claim 5, characterized in that: The nitrogen source is selected from ammonium salt, nitrate, urea, yeast extract, beef extract, corn steep liquor, peptone, fish meal or any mixture thereof; preferably ammonium salt, nitrate, urea, yeast extract, corn steep liquor or any mixture thereof, and more preferably ammonium sulfate, urea, yeast extract, corn steep liquor.
8. The preparation method according to claim 5, characterized in that: The fermentation medium also includes inorganic salts, which are selected from sulfates, phosphates, hydrochlorides, magnesium salts, manganese salts, potassium salts, sodium salts, and calcium salts, preferably dipotassium hydrogen phosphate or potassium dihydrogen phosphate, magnesium sulfate, manganese sulfate or manganese chloride, potassium chloride, sodium chloride, calcium carbonate, or a mixture of any of them.
9. The preparation method according to claim 5, characterized in that: The fermentation medium contains 10-24% glucose, 0.5-1.0% yeast extract, 0.5-1.0% corn steep liquor, 0.2-2.0% ammonium chloride, 0.05-0.3% KH2PO4, 0.001-0.01% MnSO4, 0.1-0.8% urea, 0.01-2.0% MgSO4 and 0.1-3.0% CaCO3.
10. The preparation method according to claim 5, characterized in that: The fermentation temperature is 30-37° C., the culture medium pH is 6.0-8.0, and the culture time is 48-96 hours.
11. The preparation method according to claim 5, characterized in that: The Bacillus subtilis is inoculated into the fermentation medium by seed liquid to carry out the fermentation culture; Wherein, the seed solution is obtained by culturing Bacillus subtilis HDCC12-21027 in a seed culture medium; And / or the seed culture conditions are: the seed culture temperature is 30-37°C; the medium pH is 6.0-8.0; the culture time is 8-20 hours; And / or the seed culture medium contains 5-40 g / L glucose, 2-20 g / L peptone, 3-25 g / L yeast extract, 10-50 g / L yeast extract powder, 0.2-1 g / L calcium chloride, 0.2-2 g / L magnesium sulfate, and 0.2-5 g / L potassium dihydrogen phosphate.
Citation Information
Patent Citations
High-adenosine-yield Bacillus subtilis
CN102154165B
Bacillus subtilis mutant strain, breeding method and application in fermentation method of producing adenosin
CN1724646A
